Results 211 to 220 of about 174,472 (265)
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection. [PDF]
Preechanukul A +20 more
europepmc +1 more source
Differentiation and activation antigens on CD8 T cells
Mongkolsapaya, J +2 more
openaire +1 more source
This study integrates two complementary traditional Chinese medicine components as precursors to synthesize bioactive AM‐AS@CDs. Compared with single‐component CDs, these dual‐component CDs exhibit enhanced antioxidant capacity and superior renoprotective effects.
Bixiao Liu +10 more
wiley +1 more source
Head and neck cancer therapeutic vaccines: a review. [PDF]
Huetteman A, Rabinowits G.
europepmc +1 more source
This study presents an ultrasound‐responsive nanoplatform, CS‐BT@MZ@NEs, with a BaTiO3/Mn‐Zif‐8 core and a chondroitin sulfate coating for Golgi targeting. By leveraging neutrophil hitchhiking, it enables targeted delivery to infection sites. Under ultrasound stimulation, CS‐BT@MZ@NEs generates ROS and modulates Golgi pH to activate cGAS–STING ...
Shicheng Huo +7 more
wiley +1 more source
Nanoparticle-mediated dual delivery of MHC class I and II antigens enhances T cell immunity and anti-tumor potency. [PDF]
Li E +4 more
europepmc +1 more source
Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity. [PDF]
Fu C +4 more
europepmc +1 more source
Messing with Signal 1: How Perturbed MHC Class I Antigen Presentation Contributes to Cancer. [PDF]
Lawand M +3 more
europepmc +1 more source

